Review Note

Last Update: 05/18/2024 08:18 PM

Current Deck: Clin Med::PHARM::Diabetes

New Card (Unpublished)

Currently Published Content


FrontText
FrontAudio
BackText
Helpful Tips/mnemonics
Explanations
Explanations/Helpful tips/mnemonics
Image
Add Reverse
Dumb Field

No published tags.

Pending Suggestions


Field Change Suggestions:
FrontText
Commit #99935
MOA of SGLT-2 inhibitors (flozins)
inhibiting sodium-glucose co-transporter in the proximal convoluted tubules  decrease reabsorption of glucose and increase urinary glucose excretion